Literature DB >> 1317943

Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis.

M Mori, H Kurozumi, K Akagi, Y Tanaka, S Imai, T Osato.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1317943     DOI: 10.1056/NEJM199207023270118

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: Report of a case with review of the literature.

Authors:  Miyuki Yoshii; Mitsuaki Ishida; Keiko Hodohara; Hiroko Okuno; Ryota Nakanishi; Takashi Yoshida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2012-06-12       Impact factor: 2.967

2.  Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.

Authors:  Ken H Young; Dahua Zhang; Jeffery T Malik; Eliot C Williams
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.

Authors:  B Hügle; P Suchowerskyj; H Hellebrand; B Adler; M Borte; U Sack; U Schulte Overberg-Schmidt; N Strnad; J Otto; A Meindl; V Schuster
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

4.  Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations.

Authors:  Christopher P Fox; Claire Shannon-Lowe; Martin Rowe
Journal:  Herpesviridae       Date:  2011-09-07

Review 5.  Hemophagocytic syndromes and infection.

Authors:  D N Fisman
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

6.  Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients.

Authors:  Sanghui Park; Kihyun Kim; Won Seog Kim; Keon Hee Yoo; Hong-Hoe Koo; Young-Hyeh Ko
Journal:  Virchows Arch       Date:  2008-07-18       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.